A Pharmacologic Approach Against Glioblastoma-A Synergistic Combination of a Quinoxaline-Based and a PI3K/mTOR Dual Inhibitor. [PDF]
de São José VS +5 more
europepmc +1 more source
IBS-ECDHE: A blockchain-enhanced lightweight protocol for secure cloud-IoT in biomedical HCPS. [PDF]
Rehman AU +6 more
europepmc +1 more source
A lightweight zero-trust authentication architecture for IoT via unified enhanced FAST-SM9 and dynamic re-authentication. [PDF]
Ma Z +5 more
europepmc +1 more source
From in-silico QSAR modeling to in-vitro MTT assay: experimental validation of novel uPAR leads for triple-negative breast cancer (TNBC) and skin cancer. [PDF]
Badukle H +8 more
europepmc +1 more source
Views of European Union medicine regulators and healthcare professionals on the approved versus prescribed dose of protein kinase inhibitors: an interview study. [PDF]
Brinkhof M +5 more
europepmc +1 more source
Predicting affinity and potency of new psychoactive substances at cannabinoid 1 receptor with explainable artificial intelligence. [PDF]
Schöning V +7 more
europepmc +1 more source
Comparative analysis of molecular targeted radiosensitizers in 2D and 3D cancer cell line models. [PDF]
Ramirez Parra M +5 more
europepmc +1 more source
Homologous Repair-Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy. [PDF]
Beutel AK +9 more
europepmc +1 more source
Recent Advances in Dopamine Receptor Ligands as Chemical Biology Tools. [PDF]
Dorogan M +3 more
europepmc +1 more source

